Ebola monitoring and movement of persons following exposure

Revision as of 14:30, 28 October 2014 by YazanDaaboul (talk | contribs)
Jump to navigation Jump to search

Ebola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ebola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Algorithm for the Evaluation of the Returned Traveler

Emergency Department Evaluation

Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hospital Preparedness

Checklists

Air Medical Transport

Monitoring and Movement Following Exposure

Primary Prevention

Future or Investigational Therapies

Postmortem Care

Postmortem Care

Case Studies

Case #1

Ebola monitoring and movement of persons following exposure On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebola monitoring and movement of persons following exposure

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebola monitoring and movement of persons following exposure

CDC on Ebola monitoring and movement of persons following exposure

Ebola monitoring and movement of persons following exposure in the news

Blogs on Ebola monitoring and movement of persons following exposure

Directions to Hospitals Treating ebola

Risk calculators and risk factors for Ebola monitoring and movement of persons following exposure

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Early recognition is critical to controlling the spread of Ebola virus. Health care providers should be alert for and evaluate any patients with symptoms consistent with Ebola virus disease (EVD) and potential exposure history. Standard, contact, and droplet precautions should be immediately implemented if EVD is suspected. Both clinical presentation and level of exposure should be taken into account when determining appropriate public health actions, including the need for medical evaluation or monitoring and the application of movement restrictions when indicated.

Active and Direct Active Monitoring

  • Active monitoring means that the state or local public health authority assumes responsibility for establishing regular communication with potentially exposed individuals, including checking daily to assess for the presence of symptoms and fever, rather than relying solely on individuals to self-monitor and report symptoms if they develop.
  • Direct active monitoring means the public health authority conducts active monitoring through direct observation.

The purpose of active (or direct active) monitoring is to ensure that, if individuals with epidemiologic risk factors become ill, they are identified as soon as possible after symptom onset so they can be rapidly isolated and evaluated. Active (or direct active) monitoring could be either conducted on a voluntary basis or compelled by legal order. Active (or direct active) monitoring and prompt follow-up should continue and be uninterrupted if the person travels out of the jurisdiction.

Active Monitoring

Active monitoring should consist of, at a minimum:

  • Daily reporting of measured temperatures and symptoms consistent with Ebola (including severe headache, fatigue, muscle pain, fatigue or weakness, diarrhea, vomiting, abdominal pain, or unexplained hemorrhage) by the individual to the public health authority.
  • Temperature should be measured using an FDA-approved thermometer (e.g. oral, tympanic or noncontact).
  • People being actively monitored should measure their temperature twice daily, monitor themselves for symptoms, report as directed to the public health authority, and immediately notify the public health authority if they develop fever or other symptoms. *Initial symptoms can be as nonspecific as fatigue.
  • Clinical criteria for required medical evaluation according to exposure level have been defined (see Table below), and should result in immediate isolation and evaluation. Medical evaluation may be recommended for lower temperatures or nonspecific symptoms based on exposure level and clinical presentation.

Direct Active Monitoring

For direct active monitoring, a public health authority directly observes the individual at least once daily to:

  • Review symptom status and monitor temperature
  • A second follow-up per day may be conducted by telephone in lieu of a second direct observation.
  • Direct active monitoring should include discussion of plans to work, travel, take public conveyances, or be present in congregate locations. Depending on the nature and duration of these activities, they may be permitted if the individual has been consistent with direct active monitoring (including recording and reporting of a second temperature reading each day), has a normal temperature and no symptoms whatsoever, and can ensure uninterrupted direct active monitoring by a public health authority.

For healthcare workers under direct active monitoring:

  • Public health authorities can delegate the responsibility for direct active monitoring to the healthcare facility’s occupational health program or the hospital epidemiologist.
  • Facilities may conduct direct active monitoring by performing fever checks on entry or exit from the Ebola treatment unit and facilitate reporting during days when potentially exposed healthcare workers are not working.
  • The occupational health program or hospital epidemiologist would report daily to the public health authority.

Controlled Movement

Controlled movement limits the movement of people.

  • For individuals subject to controlled movement, travel by long-distance commercial conveyances (e.g., aircraft, ship, bus, train) should not be allowed; if travel is allowed, it should be by noncommercial conveyance such as private chartered flight or private vehicle, and occur with arrangements for uninterrupted active monitoring.
  • Federal public health travel restrictions (Do Not Board) may be used to enforce controlled movement. For people subject to controlled movement, use of local public transportation (e.g., bus, subway) should be discussed with and only occur with approval of the local public health authority.

Isolation

Isolation means the separation of an individual or group who is reasonably believed to be infected with a quarantinable communicable disease from those who are not infected to prevent spread of the quarantinable communicable disease. An individual could be reasonably believed to be infected if he or she displays the signs and symptoms of the quarantinable communicable disease of concern and there is some reason to believe that an exposure had occurred.

Quarantine

Quarantine in general means the separation of an individual or group reasonably believed to have been exposed to a quarantinable communicable disease, but who is not yet ill (not presenting signs or symptoms), from others who have not been so exposed, to prevent the possible spread of the quarantinable communicable disease.

Use of Public Health Orders

Equitable and ethical use of public health orders includes supporting and compensating persons who make sacrifices in their individual liberties and freedoms for public good. Specifically, considerations must be in place to provide shelter, food and lost wage compensation, and to protect the dignity and privacy of the individual. Persons under public health orders should be treated with respect and dignity. Considerable thoughtful planning is needed to implement public health orders properly.

Early Recognition and Reporting of Suspected Ebola Virus Exposures

Early recognition is critical to controlling the spread of Ebola virus. Health care providers should be alert for and evaluate any patients with symptoms consistent with EVD and potential exposure history. Standard, contact, and droplet precautions should be immediately implemented if EVD is suspected. Both clinical presentation and level of exposure should be taken into account when determining appropriate public health actions, including the need for medical evaluation or monitoring and the application of movement restrictions when indicated.

Recommendations for Evaluating Exposure Risk to Determine Appropriate Public Health Actions

Exposure Category Clinical Criteria Public Health Actions
High Risk
  • Percutaneous (e.g., needle stick) or mucous membrane exposure to blood or body fluids of a person with Ebola while the person was symptomatic
  • Exposure to the blood or body fluids (including but not limited to feces, saliva, sweat, urine, vomit, and semen) of a person with Ebola while the person was symptomatic without appropriate personal protective equipment (PPE)
  • Processing blood or body fluids of a confirmed EVD patient without appropriate PPE or standard biosafety precautions
  • Direct contact with a dead body without appropriate PPE in a country with widespread Ebola virus transmission
  • Having lived in the immediate household and provided direct care to a person with Ebola while the person was symptomatic
Fever (subjective fever or measured temperature >= 100.4 F or 38 C) OR any of the following:
  • Severe headache
  • Muscle pain
  • Vomiting
  • Diarrhea
  • Stomach pain
  • Unexplained bruising or bleeding
  • Consideration as a probable case
  • Medical evaluation using infection control precautions for suspected Ebola, consultation with public health authorities, and testing if indicated
  • If air transport is clinically appropriate and indicated, only air medical transport (no travel on commercial conveyances permitted)
  • If infection control precautions are determined not to be indicated: conditional release and controlled movement until 21 days after last known potential exposure
Asymptomatic * Conditional release and controlled movement until 21 days after last known potential exposure
Some Risk of Exposure
  • Household contact with an EVD patient
  • Other close contact with an EVD patient in health care facilities or community settings
Fever WITH OR WITHOUT other symptoms consistent with EVD
  • Consideration as a probable case
  • Medical evaluation using initial infection control precautions for suspected Ebola, consultation with public health authorities, and testing if indicated
  • If air transport is clinically appropriate and indicated, air medical transport only (no travel on commercial conveyances permitted)
  • If infection control precautions are determined not to be indicated: Conditional release and controlled movement until 21 days after last known potential exposure
Asymptomatic or clinical criteria not met
  • Conditional release and controlled movement until 21 days after last known potential exposure
No Known Exposure
  • Having been in a country in which an EVD outbreak occurred within the past 21 days and having had no exposures
Fever WITH other symptoms consistent with EVD
  • Consideration as a person under investigation (PUI)
  • Medical evaluation and optional consultation with public health authorities to determine if movement restrictions and infection control precautions are indicated
  • If movement restrictions and infection control precautions are determined not to be indicated: travel by commercial conveyance is allowed; self-monitor until 21 days after leaving country
Asymptomatic or clinical criteria not met
  • No movement restrictions
  • Travel by commercial conveyance allowed
  • Self-monitor until 21 days after leaving country

References

Template:WH Template:WS